Rankings
▼
Calendar
KLRS Q4 2024 Earnings — Kalaris Therapeutics Inc Revenue & Financial Results | Market Cap Arena
KLRS
Kalaris Therapeutics Inc
$187M
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$20M
Net Income
-$18M
EPS (Diluted)
$-3.64
QoQ Revenue Growth
NaN%
Balance Sheet
Total Assets
$119M
Total Liabilities
$5M
Stockholders' Equity
$113M
Cash & Equivalents
$118M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$20M
-$3M
-463.6%
Net Income
-$18M
-$3M
-426.3%
← FY 2024
All Quarters
Q1 2025 →